Immunity to halothane metabolite-modified proteins in halothane hepatitis.
Kenna
J G
JG
Department of Pharmacology and Toxicology, St. Mary's Hospital Medical School (Imperial College), London, England.
Knight
T L
TL
van Pelt
F N
FN
D000818:Animals; D000917:Antibody Formation; D000941:Antigens / Q000032:analysis*; D001711:Biotransformation; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology / Q000276:immunology*; D005260:Female; D006221:Halothane / Q000378:metabolism / Q000633:toxicity*; D006801:Humans; D015151:Immunoblotting; D008099:Liver / Q000276:immunology; D008297:Male; D011817:Rabbits; D051381:Rats; D017207:Rats, Sprague-Dawley; D014269:Trifluoroacetic Acid / Q000276:immunology*
D000941:Antigens; D014269:Trifluoroacetic Acid; D006221:Halothane